Organizational learning in cooperative alliances: Some case studies in biotechnology

Technology Analysis and Strategic Management

Volumn 9, Issue 1, 1997, Pages 35-52

  Senker, Jacqueline ^a   Sharp, Margaret ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; COOPERATIVE RESEARCH; DEDICATED BIOTECHNOLOGY FIRM; ORGANISATIONAL LEARNING; RESEARCH ALLIANCE;

EID: 0030954632     PISSN: 09537325     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537329708524268     Document Type: Article

References (24)

1. J. Senker, P.-B. Joly & M. Reinhard, Overseas Biotechnology Research by Europe's Chemical/Pharmaceuticals Multinationals: Rationale and Implications, STEEP Report No. 33 (Brighton, Science Policy Research Unit, University of Sussex, 1996).
2. J. Irvine, B. Martin & P. Isard, Investing in the Future. An International Comparison of Government Funding of Academic and Related Research (Aldershot, Edward Elgar, 1990).
3. M. Kenney, Biotechnology: The University - Industrial Complex (New Haven, CT, Yale University Press, 1986).
4. M. Sharp & I. Galimberti, Coherence and Diversity. Europe's Chemical Giants and the Assimilation of Biotechnology, STEEP Discussion Paper No. 5 (Brighton, SPRU, University of Sussex, 1993).
5. M. Dibner, 'Tracking Trends in US Biotechnology', Biotechnology, 9, 1991, pp. 1334-1337.
6. Sharp & Galimberti, op. cit., Ref. 4.
7. J. Senker & M. Sharp, The Biotechnology Directorate of the SERC. Report and Evaluation of Its Achievements - 1981-87, Report to the Management Committee of the Biotechnology Directorate (Brighton, SPRU, University of Sussex, 1988).
8. Sharp & Galimberti, op. cit., Ref. 4.
9. Ernst & Young, Reform, Restructure and Renewal, 9th Annual Report on the Biotechnology Industry (Palo Alto, CA, Ernst and Young LLP, 1994), Table 13.
10. Ernst & Young, European Biotech 96: Volatility and Value, (London, Ernst & Young International, 1996).
11. J. Senker, 'National Systems of Innovation, Organizational Learning and Industrial Biotechnology', Technovation, 16, 1996, pp. 219-229.
12. D. Teece, 'Profiting from Technological Innovation', Research Policy, 15, 1986, pp. 285-306.
13. R. Coase, 'The Nature of the Firm', Economica, 4, 1937; O. E. Williamson, Markets and Hierarchies: Analysis and Antitrust Implications. A Study in the Economies of International Organizations (New York, The Free Press, 1975).
14. R. Coase, 'The Nature of the Firm', Economica, 4, 1937; O. E. Williamson, Markets and Hierarchies: Analysis and Antitrust Implications. A Study in the Economies of International Organizations (New York, The Free Press, 1975).
15. F. Chesnais, 'Technical Co-operation Agreements between Firms', STI Review, 4, 1988, p. 84.
16. W. W. Powell, 'Neither Market nor Hierarchy: Network Forms of Organisation', in: B. N. Straw & L. L. Cummings (Eds), Research in Organisational Behaviour, 12, 1990, p. 13.
17. Williamson, op. cit., Ref. 13.
18. OECD, Technology and the Economy. The Key Relationships (Paris, OECD, 1992), p. 79.
19. Teece, op. cit., Ref. 12.
20. C. Ciborra, 'Alliances as Learning Experiments: Co-operation, Competition and Change in High-tech Industries', in: L. Mytelka (Ed.), Strategic Partnerships: States, Firms and International Competition (London, Pinter Publishers, 1991).
21. M. E. Porter & M. B. Fuller, 'Coalitions and Global Strategy', in: M. E. Porter (Ed.), Competition in Global Industries (Boston, Harvard Business School Press, 1986), p. 328.
22. M. Sharp, S. Thomas & P. Martin, Technology Transfers and Innovation Policy: Chemicals and Biotechnology, STEEP Discussion Paper No. 6 (Brighton, SPRU, 1993).
23. In 1995 US partnerships accounted for 46% of alliances by UK DBFs, compared with 27% for inter-European alliances: Ernst & Young, UK Biotech 96 (London, Ernst & Young International, 1996), p. 10.
24. M. Gibbons, C. Limoges, H. Nowotny, S. Schwartman, P. Scott & M. Trow, The New Production of Knowledge (London, Sage Publication, 1994).